What type of study is this?

December 8, 2025Blood

Pre-CAR next generation sequencing informs patient outcomes in children and young adults with B-acute lymphoblastic leukemia

View Full Paper

Ask AI

Bookmark

Survival improves with lower minimal residual disease, as indicated by next generation sequencing.
Baseline measures of clonal cells and immunoglobulin heavy chain significantly influence treatment outcomes.
Cox regression analyses assess the impact of disease variables on overall survival and event-free survival.
This study supports the importance of aggregate B cell load for effective CAR-T response in B-ALL.

No takes yet. Share an insight, caveat, or question.

Retrospective analysis shows improved survival linked to lower minimal residual disease in children with B-ALL, highlighting CAR-T effectiveness.

Davis et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Retrospective analysis shows improved survival linked to lower minimal residual disease in children with B-ALL, highlighting CAR-T effectiveness.